In this study, we investigated the molecular mechanisms by which simvastatin induces cell growth arrest in HCC cells and found that simvastatin treatment results in suppression of the oncoproteins STAT3 and Skp2 and activation of the energy sensor protein AMPK. This evidence concerns the gene STAT3 and hepatocellular carcinoma.